Clinicians vary widely in prescribing sirolimus for vascular anomalies, suggesting a need for standardized guidelines.
Despite more than 15 years of data on the efficacy of sirolimus, we identified wide variation in how clinicians prescribe and manage sirolimus for patients with VAs. Future work is needed to generate data and develop evidence-based guidelines for the management of sirolimus to ensure safe and appropriate care.
No takes yet. Share an insight, caveat, or question.
Sisk et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: